It's possible that AOD9604 may influence the fat cells and lipolytic receptors, particularly given its observed association with changes in weight and fat in murine models
Whether such combinations would behave additively, synergistically, or otherwise is a research question, not an established finding
Discuss plateau duration with your PlexusDx provider to determine if intervention is needed
The treatment groups design, supplementation doses for EPA, ALA, and the combination of EPA/ALA were identical to the above-mentioned research
M., Prudhomme, D., Blanchet, R
[DOI] [PubMed] [Google Scholar] 22.Vasilaki A., Mansouri A., Remmen H.V., Meulen J.H.V.D., Larkin L., Richardson A.G., McArdle A., Faulkner J.A., Jackson M.J